Platinum-based cancer drugs destroy tumor cells by binding to DNA strands

For 30 years, the chemotherapy drug cisplatin has been one of doctors' first lines of defense against tumors, especially those of the lung, ovary and testes. While cisplatin is often effective when first given, it has a major drawback: Tumors can become resistant to the drug and start growing again.

Read the whole article on Physorg

More from Physorg